Published 14 hours ago • loading... • Updated 14 hours ago

Protein TSPYL5 Drives Paclitaxel Resistance in Triple-Negative Breast

Researchers have found that TSPYL5 promotes paclitaxel resistance in triple-negative breast cancer by stabilizing PINK1 to augment mitophagy.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

BIOENGINEER.ORG

Protein TSPYL5 Drives Paclitaxel Resistance in Triple-Negative Breast

Researchers have found that TSPYL5 promotes paclitaxel resistance in triple-negative breast cancer by stabilizing PINK1 to augment mitophagy.

14 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated14 hours agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BIOENGINEER.ORG broke the news 14 hours ago on Friday, November 13, 2026.

Sources are mostly out of (0)

Protein TSPYL5 Drives Paclitaxel Resistance in Triple-Negative Breast

1 Articles

1 Articles

Protein TSPYL5 Drives Paclitaxel Resistance in Triple-Negative Breast

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

'I Faked Cancer to Raise Money From Nigerian Public' - Blessing CEO Confesses

Experimental Blood Test Detects Early Breast Cancer and Predicts Recurrence

Combination Therapy Overcomes Treatment Resistance in Breast Cancer Models

More than 700 Breast Cancer Killers Receive Donation From a Dutch Foundation

Liquid Biopsy Technique Tracks Tumor Burden and Subtypes in Small-Cell Lung

Sarah Kuttner Beginnt Chemotherapie – Und Teilt Ihre Reise Auf Instagram

Similar News Topics

Similar News Topics

More stories like this

'I Faked Cancer to Raise Money From Nigerian Public' - Blessing CEO Confesses

Experimental Blood Test Detects Early Breast Cancer and Predicts Recurrence

Combination Therapy Overcomes Treatment Resistance in Breast Cancer Models

More than 700 Breast Cancer Killers Receive Donation From a Dutch Foundation

Liquid Biopsy Technique Tracks Tumor Burden and Subtypes in Small-Cell Lung

Sarah Kuttner Beginnt Chemotherapie – Und Teilt Ihre Reise Auf Instagram

Protein TSPYL5 Drives Paclitaxel Resistance in Triple-Negative Breast

1 Articles

1 Articles

Protein TSPYL5 Drives Paclitaxel Resistance in Triple-Negative Breast

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

'I Faked Cancer to Raise Money From Nigerian Public' - Blessing CEO Confesses

Experimental Blood Test Detects Early Breast Cancer and Predicts Recurrence

Combination Therapy Overcomes Treatment Resistance in Breast Cancer Models

More than 700 Breast Cancer Killers Receive Donation From a Dutch Foundation

Liquid Biopsy Technique Tracks Tumor Burden and Subtypes in Small-Cell Lung

Sarah Kuttner Beginnt Chemotherapie – Und Teilt Ihre Reise Auf Instagram

Similar News Topics

Similar News Topics

More stories like this

'I Faked Cancer to Raise Money From Nigerian Public' - Blessing CEO Confesses

Experimental Blood Test Detects Early Breast Cancer and Predicts Recurrence

Combination Therapy Overcomes Treatment Resistance in Breast Cancer Models

More than 700 Breast Cancer Killers Receive Donation From a Dutch Foundation

Liquid Biopsy Technique Tracks Tumor Burden and Subtypes in Small-Cell Lung

Sarah Kuttner Beginnt Chemotherapie – Und Teilt Ihre Reise Auf Instagram

Bias Distribution

Factuality